MX9302142A - Uso de 3r- y 3r,s-difenilmetoxi-1-(3,4-metileno-dioxifenetil)-piperidina y composicion que la contienen. - Google Patents

Uso de 3r- y 3r,s-difenilmetoxi-1-(3,4-metileno-dioxifenetil)-piperidina y composicion que la contienen.

Info

Publication number
MX9302142A
MX9302142A MX9302142A MX9302142A MX9302142A MX 9302142 A MX9302142 A MX 9302142A MX 9302142 A MX9302142 A MX 9302142A MX 9302142 A MX9302142 A MX 9302142A MX 9302142 A MX9302142 A MX 9302142A
Authority
MX
Mexico
Prior art keywords
diphenylmetoxy
dioxyphenethyll
piperidine
methylene
contain
Prior art date
Application number
MX9302142A
Other languages
English (en)
Inventor
Robert Michael Wallis
Stephen Alaric Williams
Original Assignee
Pfizer Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Res & Dev filed Critical Pfizer Res & Dev
Publication of MX9302142A publication Critical patent/MX9302142A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine

Abstract

El uso de 3R- y 3R,S-difenilmetoxi-1-(3,4-metilenodioxifenetil)-pi peridina para el tratamiento de condiciones que requieren antagonismo de receptores de muscarina e incremento, o prevención de la reducción, en el vaciado gástrico.
MX9302142A 1992-04-14 1993-04-13 Uso de 3r- y 3r,s-difenilmetoxi-1-(3,4-metileno-dioxifenetil)-piperidina y composicion que la contienen. MX9302142A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929208230A GB9208230D0 (en) 1992-04-14 1992-04-14 Treatment of delayed gastric emptying

Publications (1)

Publication Number Publication Date
MX9302142A true MX9302142A (es) 1994-05-31

Family

ID=10714037

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9302142A MX9302142A (es) 1992-04-14 1993-04-13 Uso de 3r- y 3r,s-difenilmetoxi-1-(3,4-metileno-dioxifenetil)-piperidina y composicion que la contienen.

Country Status (7)

Country Link
AU (1) AU3891093A (es)
GB (1) GB9208230D0 (es)
IL (1) IL105313A0 (es)
MX (1) MX9302142A (es)
TW (1) TW219331B (es)
WO (1) WO1993020819A1 (es)
ZA (1) ZA932583B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5561127A (en) * 1994-12-19 1996-10-01 Allelix Biopharmaceuticals, Inc. Muscarinic receptor ligands
EP1261282B1 (en) 2000-03-03 2013-09-25 C. R. Bard, Inc. Endoscopic tissue apposition device with multiple suction ports
US8172857B2 (en) 2004-08-27 2012-05-08 Davol, Inc. Endoscopic tissue apposition device and method of use
WO2008144602A1 (en) * 2007-05-18 2008-11-27 Auspex Pharmaceuticals, Inc. Deuterated zamifenacin derivatives

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8816365D0 (en) * 1988-07-08 1988-08-10 Pfizer Ltd Therapeutic agents

Also Published As

Publication number Publication date
ZA932583B (en) 1994-10-13
WO1993020819A1 (en) 1993-10-28
IL105313A0 (en) 1993-08-18
TW219331B (es) 1994-01-21
AU3891093A (en) 1993-11-18
GB9208230D0 (en) 1992-05-27

Similar Documents

Publication Publication Date Title
BR9814040A (pt) Agudo no pulmão com fibrose com antagonistas de avb6
YU28199A (sh) Novi oblik jedinjenja
MX9805255A (es) Antagonistas de receptor de vitronectina.
DK0705100T3 (da) Terapeutiske substituerede guanidiner
DE69421474T2 (de) Emulgierte Polysiloxanzusammensetzungen
ES2164684T3 (es) Uso de antagonistas de taquiquininas en el tratamiento de emesis.
BG105256A (en) Muscarinic agonists and antagonists
MX9202132A (es) Imidazobenzoquinonas y composicion que las contienen para prevenir o tratar la hipertension o el fallo cardiaco congestivo.
DE69311541T2 (de) Kosmetische oder pharmazeutische zusammensetzungen zur topischen anwendung die deacylierten glycerophospholipide enthalten
IT1268412B1 (it) Miscele fungicide
SE9802937D0 (sv) Novel compounds
KR100292396B1 (es)
MXPA94009086A (es) Guanidinas sustituidas terapeuticas.
TR199900505T2 (es)
PT1235579E (pt) Composicoes farmaceuticas contendo trimegestona
MX9302142A (es) Uso de 3r- y 3r,s-difenilmetoxi-1-(3,4-metileno-dioxifenetil)-piperidina y composicion que la contienen.
TR199801988T2 (xx) Kalp yetmezli�inin endotelin antagonistleri ile tedavisi i�in y�ntem.
MX9202507A (es) Composicion farmaceutica para el tratamiento de esofagitis de reflujo.
DK1100824T3 (da) Forbindelser med væksthormonfrigivende egenskaber
DK0510913T3 (da) Farmaceutiske sammensætninger indeholdende calcitonin
ES2183814T3 (es) Composicion farmaceutica que contiene il-6 y su uso para el tratamiento del trastorno trombohemorragico de consumo.
ECSP972253A (es) Composicion farmaceutica: nueva formulacion y su uso en el tratamiento y/o profilaxis de ciertos trastornos
ITMI931765A1 (it) Composizione anticancerogena per filtri di sigarette o simili e filtri trattati con detta composizione
ES1024785Y (es) Dispositivo para la formacion de motivos o composiciones anunciadoras y ornamentales.
ES1023421Y (es) Expansor patra el relleno de bolsas o similares.